80 participants
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2013-07-26
- Start Date:
- 2006-05-31
- Completion:
- 2008-11-30
Conditions
- Kidney Cancer
Interventions
- DRUG